Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction

Area of Science:

• Neuroscience
• Nanotechnology
• Pharmacology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder often linked to pesticide exposure.
• Mitochondrial dysfunction contributes to dopaminergic neuronal loss in PD.
• Current therapeutics face challenges in targeted delivery and can cause toxicity.

Purpose of the Study:

• To develop and evaluate functionalized nanoparticles for targeted drug delivery in PD.
• To assess the neuroprotective efficacy of mito-metformin encapsulated in these nanoparticles against rotenone-induced toxicity.

Main Methods:

• Polyanhydride nanoparticles (NPs) were functionalized with (3-carboxypropyl) triphenylphosphonium (CPTP).
• Neuronal uptake of functionalized and nonfunctionalized NPs was quantified.
• The efficacy of encapsulated mito-metformin in NPs against rotenone-induced mitochondrial dysfunction was evaluated.

Main Results:

• CPTP functionalization significantly enhanced NP internalization by neuronal cells.
• CPTP-functionalized NPs encapsulating mito-metformin provided significant protection against rotenone-induced mitochondrial dysfunction.
• Nonfunctionalized NPs and soluble mito-metformin showed no significant neuroprotection at equivalent doses.

Conclusions:

• Targeted, CPTP-functionalized nanoparticles improve drug delivery to neurons.
• This nano-carrier system offers enhanced dose-sparing for Parkinson's disease therapeutics.
• The platform has the potential to reduce systemic side effects of PD treatments.